Figure 4.

CD36 expression is influenced by oxLDL treatment and MNV infection. (A) CD36 mRNA expression in BMDM in response to different levels of oxLDL and the presence or absence of MNV was determined by qRT-PCR analysis. Expression levels were normalized to HPRT and expressed relative to a single replicate of the control sample (no oxLDL, no MNV) (B) Cell-surface expression of CD36 protein was determined in response to MNV in the presence or absence of oxLDL from triplicate samples per treatment by using flow cytometry. The fluorescent intensity (bar, mean ± SEM) of triplicate samples is shown.